Intrepid Financial Planning Group LLC increased its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,855 shares of the company’s stock after acquiring an additional 851 […]
Eli Lilly and Company (NYSE:LLY – Get Free Report) CAO Donald A. Zakrowski sold 750 shares of the firm’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $819.47, for a total transaction of $614,602.50. Following the sale, the chief accounting officer now owns 7,130 shares of […]
Eli Lilly and Company (NYSE:LLY – Get Free Report) EVP Johna Norton sold 7,056 shares of Eli Lilly and Company stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $819.38, for a total value of $5,781,545.28. Following the sale, the executive vice president now directly owns 25,428 […]
CIBC Private Wealth Group LLC reduced its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 751,276 shares of the company’s stock after selling 147 shares during the quarter. […]
Shepherd Financial Partners LLC trimmed its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,120 shares of the company’s stock after selling 59 shares during the quarter. Eli Lilly and Company […]